| Literature DB >> 35409844 |
Rebecca Baxter1, Erik K Fromme2,3, Anna Sandgren1.
Abstract
Serious illness conversations aim to align medical care and treatment with patients' values, goals, priorities, and preferences. Timely and accurate identification of patients for serious illness conversations is essential; however, existent methods for patient identification in different settings and population groups have not been compared and contrasted. This study aimed to examine the current literature regarding patient identification for serious illness conversations within the context of the Serious Illness Care Program and/or the Serious Illness Conversation Guide. A scoping review was conducted using the Joanna Briggs Institute guidelines. A comprehensive search was undertaken in four databases for literature published between January 2014 and September 2021. In total, 39 articles met the criteria for inclusion. This review found that patients were primarily identified for serious illness conversations using clinical/diagnostic triggers, the 'surprise question', or a combination of methods. A diverse assortment of clinicians and non-clinical resources were described in the identification process, including physicians, nurses, allied health staff, administrative staff, and automated algorithms. Facilitators and barriers to patient identification are elucidated. Future research should test the efficacy of adapted identification methods and explore how clinicians inform judgements surrounding patient identification.Entities:
Keywords: advance care planning; end of life; palliative care; patient identification systems; review; scoping review; serious illness care program; serious illness communication; serious illness conversations
Mesh:
Year: 2022 PMID: 35409844 PMCID: PMC8998898 DOI: 10.3390/ijerph19074162
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Summary of study selection process—PRISMA-ScR.
Description of patient identification †.
| Article | Method | How Patients Were Identified for Serious Illness Conversations (Actual or Planned) | Who Identified the Patient |
|---|---|---|---|
| Dana-Farber Neuro-oncology Pilot Cluster ( | |||
| Bernacki et al. (2015) [ | SQ (1 year) and clinical/diagnostic triggers | To identify eligible patients, we use a ‘No’ answer to the SQ (p. 5). Recruitment in the neuro-oncology clinic also included a review of ICD-9 codes to identify patients with a diagnosis of a cancer that has a high mortality risk (e.g., glioblastoma multiforme) (p. 6). | Patients are identified by a |
| Miranda et al. (2018) [ | SQ (1 year) and clinical/diagnostic triggers | Patients were screened for inclusion either by chart review for a documented diagnosis of glioblastoma, OR by asking their clinician the SQ. Patients with a documented glioblastoma diagnosis, or for whom the answer to the SQ was ‘no’, were eligible (p. 805). | Not explicitly stated who conducted chart review. |
|
| |||
| Geerse et al. (2019) [ | SQ (1 year) | Clinicians systematically used the SQ to identify eligible patients with advanced cancer whom they believed were at risk of dying within one year (p. 774). | |
| Paladino et al. (2019) [ | SQ (1 year) | The SQ was applied at regular intervals by oncology clinicians to lists of their patients (p. 803). | |
| Bernacki et al. (2019) [ | SQ (1 year) | Enrolled oncology clinicians identified eligible patients by reviewing patient lists at regular intervals and answering the SQ. Patients for whom clinicians responded no were eligible for participation (p. 752). | Enrolled |
| Paladino et al. (2020) [ | SQ (1 year) | Eligible patients were… identified by their oncology clinician with a ‘no’ response to the SQ (p. 4551). | |
| Paladino et al. (2020) [ | SQ (1 year) | To identify eligible patients… all clinicians used SQ. Only patients for whom the clinician responded ‘no, I would not be surprised’ were eligible (p. 1366). | All |
| Sanders et al. (2020) [ | SQ | Systematic identification of patients using the SQ (p. 890). | Not explicitly stated who identified patients. |
|
| |||
| Lakin et al. (2017) [ | SQ (2 years) and clinician judgement | Clinicians each answered the SQ… Clinicians could also add patients to and remove them from their lists based on their clinical judgment (p. 1260). | Patients were identified by |
| Lakin et al. (2019) [ | SQ (2 years) and clinical/diagnostic triggers | Primary care providers reviewed lists of eligible patients and select the most appropriate patients to enroll in the iCMP. Then, to identify which iCMP patients were eligible for the SICP, primary care physicians and nurse care coordinators answered the 2-year SQ (p. 1468). | |
| Lakin et al. (2019) [ | Clinician judgement | Patient screening: The interviewee is discussing their process for how they do patient selection or identification—‘When I do patient selection, I sit down and look at a list of patients and just choose.’ Spontaneous patient selection: The interviewee talks about times when they have a conversation with a patient organically, rather than planned in advance—‘Sometimes I am talking to the patient and I realize that it’s just time to have the conversation’ (p. 760). | |
| Lakin et al. (2020) [ | SQ (2 years) and clinical/diagnostic triggers | Patients who had been enrolled in the iCMP, had complex medical histories, and were well-known to the clinicians who identified them for a serious illness conversation via electronic surveys using the SQ (p. 100431). | |
| Paladino et al. (2021) [ | SQ (1 year), clinical/diagnostic triggers, and patient/family request | Clinicians described three approaches to selecting patients for conversations: (1) Use of the SQ by reviewing lists of patients identified as high-risk (2) Response to a triggering medical event or assessment of the patient’s health status, which led clinicians to initiate a discussion; (3) Responding to patient- or family-initiated statements that clinicians interpreted as a sign of readiness for the conversation (p. 461). | |
|
| |||
| Manz et al. (2020) [ | Clinical/diagnostic triggers | An EHR-based machine learning algorithm uses real-time patient data, including demographic information, comorbidities, lab values, and encounters with the health system over the prior six months, to estimate individuals’ risk of dying in the subsequent six months (p. 2). Clinicians could view a list of up to six patients scheduled for a visit in the coming week with the highest-risk of machine-predicted six-month mortality (p. 4). | |
| Manz et al. (2020) [ | Clinical/diagnostic triggers | Clinicians could review a list of patients scheduled for the following week in their clinic who had a high risk of mortality. Mortality risk was determined by a machine learning algorithm, which used structured EHR data to predict risk of 180-day mortality. Clinicians could view a list of up to 6 patients with the highest predicted 180-day mortality risk (p. 3). | |
|
| |||
| Gace et al. (2020) [ | Clinical/diagnostic triggers | An automated, EHR embedded screening tool identified patients at increased risk for unmet palliative needs. This Epic algorithm scanned the patient registry, problem list and progress notes to identify inpatients with high-risk diagnoses; limited prognosis; and language regarding the need for advance care planning, palliative care, or family meetings. Patients who met any criteria were considered to have a positive screen and were said to have ‘triggered’ the tool (p. 1494). | An |
| Greenwald et al. (2020) [ | Clinical/diagnostic triggers | An automated electronic screening tool identified patients who were at risk for potential unmet palliative care needs (p. 1501). Hospitalists on intervention units received verbal notification when their recently admitted patients were identified using a computer algorithm as having possible unmet palliative needs. Hospitalists on the control unit received no notifications (p. 1500). | A |
|
| |||
| Lamas et al. (2017) [ | Clinical/diagnostic triggers | We defined chronically critically ill patients as those who had undergone tracheotomy for prolonged mechanical ventilation. The admitted critical chronic illness patients were screened, and patients or surrogates were approached within two weeks of admission (p. 712). | |
| Massman et al. (2019) [ | Clinical/diagnostic triggers | Primary triggers (1 or more): Any metastatic solid tumor; COPD with home O2 and/or FEV1 < 35% predicted; History of CHF; CKD Stage IV or V; Chronic liver disease with cirrhosis and/or ascites; Age > 90 years. Secondary triggers: A1c > 8.5; >2 emergency department visits and/or hospitalizations in past 6 months; Functional decline; Cognitive status; Noncompliance; Age > 80 years (p. 293). | A report function was built in the |
| Mandel et al. (2017) [ | SQ (1 year), clinical/diagnostic triggers, and person/family request | Before dialysis—Not surprised in answer to SQ; High likelihood of progression to ESRD; Dialysis modality teaching referral; Access referral; Access placement; Transplant referral; Recurrent or prolonged hospitalizations; Changes in function or dependence; Sentinel events or indicators; Patient or family request (p. 856). | Not explicitly stated who would undertake identification. Article outlines that patients generally expect such conversations to be initiated by their |
| O’Donnell et al. (2018) [ | SQ (1 year) and clinical/diagnostic triggers | Patients currently or recently hospitalized with at least one poor prognostic indicator (p. 517): hospitalization for heart failure management within a year prior to the index hospitalization; age ≥ 80 years; advanced CKD; SBP ≤ 100 mm Hg; serum sodium ≤ 130 mEq/L; cardiogenic shock; serious non-cardiovascular illness limiting 1-year life expectancy: using SQ (Supplement 2, p. 2). | |
| Totten et al. (2019) [ | SQ (2 years) and clinical/diagnostic triggers | Patients may have any serious illnesses or conditions that are likely to limit their life expectancy to less than two years as defined by using clinical intuition (e.g., SQ) alone, or supplemented by an available algorithm (mortality index) (p. S-85). | Clinician-focused model: the |
| Billie and Letizia (2020) [ | Clinical/diagnostic triggers | Unplanned inpatient admission in the last six months; And one or more of the following: Cancer (poor prognosis, metastatic or hematological); COPD or interstitial lung disease (only if using home oxygen or hospitalized); Renal failure (end stage); Congestive heart failure (only if hospitalized); Advanced liver disease or cirrhosis; Diabetes with severe complications (p. 225). | Transitions- of-care referrals were identified daily from an |
| Kumar et al. (2020) [ | SQ (1 year) | Patients were considered eligible if clinicians answered ‘no’ to the SQ (p. e1508). | |
| Lakin et al. (2020) [ | SQ (1 and 2 year) and clinical/diagnostic triggers | University of Pennsylvania Health System: Printed weekly patient schedules for physician review using the SQ with a 1-year duration. Later changed to system where provider selected patients ad hoc (p. 2). | University of Pennsylvania Health System: (1) |
| Lally et al. (2020) [ | Clinical/diagnostic triggers | A daily dashboard identifies when ACO patients are admitted to the hospital, and patients who meet the criteria for CCM were enrolled. Any patient identified on this daily report is added to a spreadsheet and the data analyst looks for a documented serious illness conversation within 14 days of discharge from the hospital (p. 113). | A |
| Ma et al. (2020) [ | Clinical/diagnostic triggers | Patients were eligible to be enrolled in the SICP if they were admitted to a medical ward, had a stay of at least 48 hours, and received a score of 5 or 6 on the interRAI Emergency Department Screener on admission (p. E449). | The |
| Pasricha et al. (2020) [ | Clinical/diagnostic triggers | Providers met with surrogates of adult, mechanically ventilated patients in the medical intensive care unit within 48 hours of intubation (p. 120). | Not explicitly stated who identified patients. |
| Pottash et al. (2020) [ | Clinical/diagnostic triggers | Patients with a chronic, serious illness were identified by hospital record search using the following criteria: (1) admitted in the previous six months for either lung disease, liver disease, heart failure, or stroke/dementia; and, (2) a physician trainee had written a note in their chart (p. 1188). | Patients were identified by |
| Wasp et al. (2020) [ | Clinical/diagnostic triggers and clinician judgement | Fellows identified a range of patients who they felt were appropriate candidates for a serious illness conversation: patients within hours to days of death, to those with incurable cancer failing treatment, and those with personal or family emotional distress (p. 4). | |
| DeCourcey et al. (2021) [ | Clinical/diagnostic triggers | The preliminary PediSICP intervention [was] tentatively triggered by prolonged inpatient hospitalization (>2 weeks) or a hospital readmission (p. 248). | Patient and parent participants were either |
| Hafid et al. (2021) [ | Clinical/diagnostic triggers | Patients aged 65 or older with any diagnosis of a chronic, progressive illness or frailty that is expected to decrease life expectancy (p. 3). | |
| Karim et al. (2021) [ | SQ (1 year) and clinical/diagnostic triggers | The patient met one or more of the following criteria: a response of ‘no’ to the SQ, any patient with a diagnosis of metastatic pancreatic cancer, or symptom scores of >7 on more than three categories on our patient-reported outcome dashboard (p. 906). | The |
| Lakin et al. (2021) [ | Clinical/diagnostic triggers | Patients were screened using pre-defined EMR-based criteria, which included attribution to the Brigham & Women’s Hospital ACO, in addition to one of two additional clinical criteria: (1) age over 80, or (2) age 75–79 with two or more admissions in the preceding six months (p. 2). | Screened by pre-defined |
| Le et al. (2021) [ | SQ (1 year) | The original criteria to indicate a serious illness conversation was that only one team member had to not be surprised if a patient died within the next year. Feedback from some staff indicated they would prefer to be in full agreement to indicate a conversation. Thereafter, all team members needed to be in agreement about the SQ answer (p. 1014). | Patients were identified during |
| Paladino et al. (2021) [ | Clinical/diagnostic triggers | Outpatient setting: clinicians to proactively reach out to patients in the community with underlying health conditions who are at higher risk of serious complications should they contract COVID-19. Inpatient setting: clinicians to have ACP conversations with patients admitted to the hospital with confirmed or suspected COVID-19 (or their families) (p. 129). | Outpatient setting: |
| Schmidt et al. (2021) [ | Clinical/diagnostic triggers | Eligible patients must: be seriously ill or frail; be expected to live 1 to 2 years; and, have participated in an ACP conversation with trained clinicians and nursing staff. Marking patients on the office schedule for clinicians using the Gagne Index (p. 2). Trigger: Mortality score of 14.6% or higher (p. 3). | |
| Swiderski et al. (2021) [ | SQ (2 years) | Physicians identified patients using a modified SQ (p. 2). | |
| Thamcharoen et al. (2021) [ | Clinical/diagnostic triggers | Patients with CKD stage ≥ 3B with the following criteria: age ≥ 80 years or; age ≥ 70 years with diabetes or cardiovascular disease or; any age with other advanced stage organ diseases, such as: heart failure with New York Heart Association class III or IV, severe COPD, cirrhosis with child class C or Model for End-Stage Liver Disease score ≥ 17, any age with metastatic cancer, or any age with CKD stage 4 or 5 (p. 3). | Not explicitly stated who identified patients. Participants completed the adapted SICG in person with a |
† All data originated from, or was adapted from, the associated source indicated in the table. Abbreviations: A1c—glycated hemoglobin; ACO—Accountable Care Organization; ACP—Advance Care Planning; CCM—Complex Care Management; CHF—Chronic Heart Failure; CKD—Chronic Kidney Disease; COPD—Chronic Obstructive Pulmonary Disease; EHR—Electronic Health Record; EMR—Electronic Medical Record; ESRD—End-Stage Renal Disease; FEV1—Forced Expiratory Volume 1 second; ICD—International Classification of Diseases; iCMP—Integrated Care Management Program; interRAI—International Resident Assessment Instrument; mmHG—millimeters of mercury; mEq/L -milliequivalents per liter; O2—Oxygen; SBP—Systolic Blood Pressure; SQ—Surprise Question; U.K.—United Kingdom.
Identification methods among population groups and clinical settings/contexts *.
| Clinical Setting/Context † | SQ | Clinical/Diagnostic Triggers | Clinician Judgement | SQ and Clinical/Diagnostic Triggers | SQ and Clinician Judgement | SQ and Clinical/Diagnostic | Clinical/Diagnostic Triggers and Clinician Judgement |
|---|---|---|---|---|---|---|---|
| Oncology-Inpatient/Outpatient | (3, 4, 5, 22, 23, 24) ‡, 40 | (30, 31) ¶ | (6, 21) §, 48 | 45 | |||
| Primary Care-Urban/Rural | 35, 39, 52 | (27) ‖ | (26, 28) ‖, 38 | (25) ‖ | (29) ‖ | ||
| Medical-Inpatient/Outpatient | 50 | (32, 33) ††, 34, 37, 42, 47, 49 | |||||
| Intensive Care | 43 | ||||||
| COVID-19 | 51 | ||||||
| End-stage renal failure/Nephrology | 54 | 36 | |||||
| Pediatrics | 46 | ||||||
| Community Care/Health | 53 | 41 | |||||
| Ambulatory Care | 44 |
* Sources in brackets denote connection to a study cluster, indicated in the table footnotes; † Lakin et al. [12] not listed due to multiple clinical settings and identification methods; ‡ Dana-Farber Neuro-oncology Pilot Cluster; § Dana-Farber Cluster Randomized Trial Cluster; ‖ Brigham Primary Care Integrated Care Management Program Cluster; ¶ University of Pennsylvania Machine Learning Cluster Randomized Trial; †† Massachusetts General Hospital Cluster.
Database search strategy.
| Database | Search Strategy |
|---|---|
| CINAHL | TI (“serious illness communication” OR “serious illness program *” OR “serious illness care” OR “serious illness conversation *” OR “serious illness model”) OR AB (“serious illness communication” OR“serious illness program *” OR “serious illness care” OR “serious illness conversation *” OR “serious illness model”) |
| MedLine | TI (“serious illness communication” OR “serious illness program *” OR “serious illness care” OR “serious illness conversation *” OR “serious illness model”) OR AB (“serious illness communication” OR“serious illness program *” OR “serious illness care” OR “serious illness conversation *” OR “serious illness model”) |
| PsychInfo | TI (“serious illness communication” OR “serious illness program *” OR “serious illness care” OR “serious illness conversation *” OR “serious illness model”) OR AB (“serious illness communication” OR “serious illness program *” OR “serious illness care” OR “serious illness conversation *” OR “serious illness model”) OR KW (“serious illness communication” OR “serious illness program *” OR “serious illness care” OR “serious illness conversation *” OR “serious illness model”) |
| PubMed | ((((“serious illness communication”[Title/Abstract]) OR (“serious illness program *”[Title/Abstract])) OR (“serious illness care”[Title/Abstract])) OR (“serious illness conversation *”[Title/Abstract])) OR (“serious illness model”[Title/Abstract]) |
Note: The terms “serious illness program *” and “serious illness model” were not recognized by PubMed.
Characteristics of the included literature †.
| Author/s, Year, Country | Aim/s | Design/Methods/Context | Participant Characteristics | Results/Conclusions | |
|---|---|---|---|---|---|
| Participants | Female | ||||
| Bernacki et al. (2015) ‡ | This article describes the protocol for a cluster randomized controlled trial of a multicomponent, structured communication intervention. | Study protocol, prospective, cluster randomized controlled trial. | - | - | We believe that developing scalable models for improving SICs will contribute to better alignment of healthcare with the preferences of oncology patients, and eventual extension to other patient populations and care settings. |
| Lakin et al. (2017) ¶ | Describes the implementation of the program and our evaluation of the use of the program by clinicians and the intervention’s impact on the prevalence, timing, accessibility, and comprehensiveness of documented SICs and hospice use among patients. | Prospective implementation trial. | Patients: | 46 (45.6%) | Patients in the clinics with the program implemented were more likely than those in comparison clinics to have SICs-including discussion of values and goals-documented in patients’ medical records. Clinicians who participated also reported high satisfaction with training they received as part of the program, which they regarded as effective. |
| Lamas et al. (2017) | To determine the feasibility, acceptability, and potential usefulness of conversations about serious illness with chronic critical illness patients or their surrogate decision makers after LTACH admission. | Exploratory pilot study. | Patient = 30 | 10 (33%) | Conversations about serious illness care goals can be accomplished in a relatively short period of time, are acceptable to chronically critically ill patients and their surrogate decision makers in the LTACH, and are perceived as worthwhile by patients, surrogates, and clinicians. |
| Mandel et al. (2017) | (To) (1) identify the barriers to SICs in the dialysis population, (2) review best practices in and specific approaches to conducting SICs, and (3) offer solutions to overcome barriers as well as practical advice, including specific language and tools, to implement SICs in the dialysis population. | Special issue article. | - | - | Implementing SICs for patients on dialysis involves identifying patients at the highest risk of adverse outcomes, triggering conversations, and conducting them routinely. The Guide provides a tested, scalable structure for conducting these conversations that can be used by nephrologists and other dialysis clinicians, and it can be adapted further to meet the needs of this population. Documentation and sharing of conversation content and identification of metrics to drive performance improvement are also essential to the successful implementation of SICs for patients on dialysis. |
| Miranda et al. (2018) ‡ | To describe the prevalence, timing, and quality of documented SICs and evaluate their focus on patient goals/priorities. | Retrospective chart review, descriptive. | Staff = 6 | 3 (50%) | Patients with GBM had multiple goals/priorities with potential treatment implications, but documentation showed SICs occurred relatively late and infrequently reflected patient goals/priorities. |
| O’Donnell et al. (2018) | To determine if early initiation of goals of care conversations by a palliative care-trained social worker would improve prognostic understanding, elicit advanced care preferences, and influence care plans for high-risk patients discharged after HF hospitalization. | Prospective randomized clinical trial. | Patients = 50 | 12 (46.2%) | Without an adverse impact on quality of life, prognostic understanding, and patient–physician communication regarding goals of care may be enhanced by a focused, social worker–led palliative care intervention that begins in the hospital and continues in the outpatient setting. |
| Geerse et al. (2019) ‖ | To characterize the content of SICs and identify opportunities for improvement. | Cluster randomized trial, descriptive qualitative. | Staff = 16 | 8 (50%) | Exploratory data from this subset of the Dana-Farber cluster-randomized trial suggest that seriously ill patients are open to discussing values and goals with their clinician. Yet, clinicians may struggle when disclosing a time-based prognosis and in responding to patients’ emotions. |
| Lakin et al. (2019) ¶ | To explore the perceptions of primary care clinicians about interprofessional work in serious illness communication. | Descriptive qualitative. | Staff = 14 | 10 (71.4%) | This study suggests three key areas of focus for design and implementation of programs aimed at improving SICs by interprofessional primary care teams: establishing clear professional roles and responsibilities, paying special attention to interprofessional and clinician-patient relationships, and clearly structuring interventions aiming to change the way our system drives serious illness communication. |
| Paladino et al. (2019) ‖ | To evaluate the efficacy of a communication quality-improvement intervention in improving the occurrence, timing, quality, and accessibility of documented SICs between oncology clinicians and patients with advanced cancer. | Cluster randomized clinical trial. | Staff | 23 (62%) | This communication quality-improvement intervention resulted in more, earlier, better, and more accessible SICs documented in the EMR. |
| Bernacki et al. (2019) ‖ | To examine feasibility, acceptability, and effect of a communication quality-improvement intervention (SICP) on patient outcomes. | Cluster randomized clinical trial. | Staff = 91 | 52 (57.1%) | The results of this cluster randomized clinical trial were null with respect to the co-primary outcomes of GCC and peacefulness at the end of life. However, the significant reductions in anxiety and depression in the intervention group are clinically meaningful and require further study. |
| Lakin et al. (2019) ¶ | To evaluate the effectiveness of a clinician screening tool to identify patients for a communication intervention. | Prospective | Staff: | 37 (56.1%) | When used in combination with a high-risk algorithm, the 2-year version of the SQ captured the majority of patients who died, demonstrating better than expected performance as a screening tool for a serious illness communication intervention in a heterogeneous primary care population. |
| Totten et al. (2019) | We are conducting a cluster randomized trial comparing team-based to clinician-focused ACP using the SICP. | Protocol for a cluster randomized trial. | - | - | Our dissemination will report the results of comparing the two models and the implementation experience of the practices to create guidance for the spread of ACP in primary care. |
| Massman et al. (2019) | To provide a structure within a primary care clinic to facilitate conversations with seriously ill individuals about their care preferences. | Implementation study. | Staff = 5 | 4 (80%) | Provider perceptions of conversations after implementation were positive. During the pilot, 3 SICs were initiated with additional patients prepared for future conversations using an information sheet and introduction to the conversation. |
| Manz, et al. (2020) †† | Describes the design of a stepped-wedge cluster randomized trial to evaluate the impact of an intervention that employs machine learning-based prognostic algorithms and behavioral nudges to prompt oncologists to have SICs with patients at high risk of short-term mortality. | Stepped-wedge cluster randomized controlled trial. | - | - | This trial represents a novel application of machine-generated mortality predictions combined with behavioral nudges in the routine care of outpatients with cancer. |
| Billie and Letizia (2020) | To develop, implement, and evaluate an educational program and a serious illness protocol for a case management team of nurses and social workers. | A case management quality improvement project–pre/post intervention test. | Staff = 20 | 20 (100%) | Serious Illness Protocol: The case managers correctly identified 92% of patients who met the established identification criteria for this project. In 91.8% of cases, the case managers conducted a SIC in adherence to the protocol. In 76% of the cases, documentation about the SIC was completed in accordance with the protocol. |
| Paladino et al. (2020) ‖ | To determine the effect of the SICP on health care utilization at the end of life in oncology. | Cluster-randomized trial. | Patients Int. = 74 (62 y) | 41 (55%) | Intervention and control patients had similar end-of-life health care utilization as measured by the mean number of NQF-endorsed indicators. |
| Pasricha et al. (2020) | To examine the feasibility, acceptability, and utility of a standardized SIC to guide communication between nonpalliative care trained providers and surrogates of critically ill, mechanically ventilated patients. | Mixed-methods quality improvement pilot study. | Staff = 9 | - | We found that implementation of a structured communication tool in the intensive care unit was feasible and acceptable to surrogates and providers; yet, fidelity to the timing and completion was modest. The tool appeared to yield valuable information for understanding the goals, fears, and care preferences of mechanically ventilated patients. |
| Lakin et al. (2020) ¶ | This study explores whether an intervention to improve conversations about patients’ goals in a primary care setting could improve the value of healthcare delivered. | Secondary analysis of a quality improvement intervention. | Patients = 84 (83.1 y) | 47 (56%) | Possible savings observed in this study are similar in magnitude to previous studies in advance care planning and specialty palliative care but occur earlier in the disease course and in the context of documented conversations and a comprehensive, interprofessional case management program. |
| Paladino et al. (2020) ‖ | This analysis evaluates the patient and clinician experience of a conversation using a SICG. | Secondary analysis from a cluster-randomized clinical trial. | Staff = 54 | - | Conversations using a SICG were feasible, acceptable, and associated with positive experiences for both patients and clinicians in oncology in ways that align with national recommendations for serious illness communication. |
| Lakin et al. (2020) | To describe the strategies used by a collection of healthcare systems to apply different methods of identifying seriously ill patients for a targeted palliative care intervention to improve communication around goals and values. | Implementation case series. | - | - | Involving clinical and program staff to choose a simple initial method for patient identification is the ideal starting place for selecting patients for palliative care interventions. However, improving and refining methods over time is important and we need ongoing research into better patient selection methodologies that move beyond mortality prediction and instead focus on identifying seriously ill patients—those with poor quality of life, worsening functional status, and medical care that is negatively impacting their families. |
| Pottash et al. (2020) | To test the acceptability of incorporating a SIC into routine trainee practice. | Acceptability study, descriptive (mixed methods). | Staff = 21 | 5 (23%) | With preparation, time, and a conversation guide, trainees completed the elements of a SIC and found it to be an important addition to their routine practice. Patients found the conversation to be important, reassuring, and of better quality than their usual visits. |
| Ma et al. (2020) | To assess whether the quality of conversations about serious illness improved after implementation of the SICP. | Retrospective chart review study. | Staff = 21 | 30 (53.6%) | Implementation of the SICP in a hospital setting was associated with higher quality of documented conversations regarding serious illness with patients at high risk for clinical or functional deterioration. The SICP is transferable and adaptable to a hospital setting, and was associated with an increase in adherence to best practices compared to usual care. |
| Wasp et al. (2020) | We developed and tested an implementation strategy for incorporating the SICG into hematology-oncology fellowship training. | Prospective, single-center, cohort implementation study. | Staff = 8 | 4 (50%) | Despite acquisition of communication skills, promoting new clinical behaviors remains challenging. More work is needed to identify which implementation strategies are required in this learner population. |
| Kumar et al. (2020) | To characterize the experiences and perceptions of patients engaging in SICs as part of routine oncology care in the setting of SICP implementation. | Prospective, cross-sectional quality improvement evaluation. | Patients = 32 | 17 (53%) | SICs are generally acceptable to oncology patients (non-harmful to the vast majority, positive for many). Our qualitative analysis suggests a positive impact on prognostic understanding and end-of-life planning, but opportunities for improvement in the delivery of prognosis and preparing patients for SICs. |
| Sanders et al. (2020) ‖ | To describe our measurement approach to GCC, present findings from a post-hoc analysis of trial data, and discuss lessons learned about measuring GCC. | Secondary analysis of trial data. | Patients = 203 | 106 (53%) | Measuring GCC remains a fundamental challenge to palliative care researchers. Ratings attest to the fact that many things matter to patients; however, rankings can better determine what matters most. |
| Gace et al. (2020) ‡‡ | To assess patients’ experience and perception of the quality of goals and values conversations. | Two group cohort trial. | Int. = 75 (69.8 y) | 40 (53.3%) | This study suggests that informing the care team regarding their patients’ potential unmet palliative care needs is associated with patients reporting improved experience of their care without adverse effects on their mood. |
| Greenwald et al. (2020) ‡‡ | To assess the impact on hospitalists of a system that reminds them to have SICs with their patients identified with potential unmet palliative needs. | Two group cohort trial. | Staff = 61 | 31 (50.8%) | Routinely informing hospitalists when their patients were identified as being at increased risk for unmet palliative needs did not increase the sense of meaning these providers achieved. |
| Lally et al. (2020) | We undertook a project to increase the number of SICs occurring in an ACO using a script delivered telephonically by nurse care managers. | Quality improvement implementation. | - | - | This project demonstrates a unique way to modify the SICG for use by nurses as part of a health care team. |
| Manz et al. (2020) †† | To determine the effect of a clinician-directed intervention integrating machine learning mortality predictions with behavioral nudges on motivating clinician-patient SICs. | Stepped-wedge cluster randomized clinical trial. | Staff = 78 | 6426 (52.8%) | Behavioral nudges combined with machine learning mortality predictions can positively influence clinician behavior and may be applied more broadly to improve care near the end of life. |
| Lakin et al. (2021) | To assess the implementation of the SAGE program in a population of patients hospitalized on a general medical service. | Quality improvement implementation. | Patients:Int. = 64 (85.8 y) | 38 (59.4%) | This study demonstrated significant differences in the frequency and quality of SICs completed earlier in the illness course for hospitalized patients. |
| Paladino et al. (2021) | Describe(s) the tool development strategy, the themes that emerged from stakeholder engagement, and the two communication guides that resulted from this process. | Adaptation of SICG for COVID-19. | - | - | Well-designed communication tools and implementation strategies can equip clinicians to foster connection with patients and promote shared decision making. Although not an antidote to this crisis, such high-quality ACP may be one of the most powerful tools we have to prevent or ameliorate suffering due to COVID-19. |
| Paladino et al. (2021) ¶ | To explore practical aspects of SICP implementation. | Qualitative descriptive. | Staff = 14 | 10 (71.4%) | The shifts in processes employed by inter-professional clinicians revealed comprehensive models for prognostic communication and creative workflows to ensure that patients with complex illnesses had proactive, longitudinal, and patient-centered SICs and care planning. |
| Thamcharoen et al. (2021) | This pilot study aimed to explore whether use of the SICG to aid early ACP is acceptable, and to evaluate the information gained from these conversations. | Mixed-methods implementation study. | Patients = 26 (78y) | 13 (50%) | Patients in this pilot study found the adapted SICG acceptable. This guide may be used with patients early in the course of advanced kidney disease to gather information for future ACP. |
| Schmidt et al. (2021) | To find better methods for increasing patient recruitment for the ACP study. | Intervention study. | Staff = 14 | 11 (79%) | Notifying clinical staff about potential study participants increased patient referrals in this ACP study. |
| Swiderski et al. (2021) | (To) explore(s) the experiences of primary care physicians who participated in an initiative to implement structured SICs. | Descriptive qualitative. | Staff = 11 | 8 (72.7%) | Physicians at CHCs identified challenges in SICs at personal, interpersonal, organizational, and societal levels. |
| Hafid et al. (2021) | The objective of this study was to implement ACP through adapted SICP training sessions, and to understand PCP perceptions of implementing ACP into practice. | Mixed-methods quality improvement study. | Staff = 34 | 26 (76%) | Training in ACP conversations improved PCPs’ individual perceived abilities, but discomfort and other barriers were identified. |
| Karim et al. (2021) | The aims of this initiative was to identify at least 24 patients (12 patients per clinic) for SIC and that at least 95% of all conversations would be documented in the EMR. | Implementation study. | Staff = 2 | 10 (62.5%) | Implementation of the SICP resulted in increased rates of documentation, but the target number of conversations was not met. |
| Le et al. (2021) | To investigate the feasibility of using the SQ to identify patients who would benefit from early SICs and study any changes in the interdisciplinary team’s beliefs, confidence, and engagement as a result of asking the SQ. | Prospective cohort pilot study. | Staff = 97 | - | There are ethical and practical issues as to what constitutes a ‘serious illness’ and if answering ‘no’ to the SQ always equates to a conversation. The barriers of time constraints and lack of training call for institutional change in order to prioritize the moral obligation of SICs. |
| DeCourcey et al. (2021) | To develop a generalizable ACP intervention for children, adolescents, and young adults with serious illness using a multistage, stakeholder-driven approach. | Intervention development and adaptation. | Staff = 34 | 26 (76.5%) | The finalized PediSICP intervention includes a structured HCP and family ACP communication occasion supported by a 3-part communication tool and bolstered by focused HCP training. We also identified strategies to ameliorate implementation barriers. |
* Age reported as mean (in years); † All data originated from, or was adapted from, the associated source indicated in the table; ‡ Dana-Farber Neuro-oncology Pilot Cluster; ‖ Dana-Farber Cluster Randomized Trial Cluster; ¶ Brigham Primary Care Integrated Care Management Program Cluster; †† University of Pennsylvania Machine Learning Cluster Randomized Trial; ‡‡ Massachusetts General Hospital Cluster. Abbreviations: ACO—Accountable Care Organization; ACP—Advance Care Planning; CHC—Community Health Centre; Cont.—Control; EMR—Electronic Medical Record; GBM—Glioblastoma Multiforme; GCC—Goal Concordant Care; HCP—Health Care Professional; HF—Heart Failure; Int.—Intervention; LTACH—Long-Term Acute Care Hospital; NSQ—Nurse Surprise Question; NQF—National Quality Forum; PCP—Primary Care Provider; PSQ—Physician Surprise Question; SAGE—Speaking About Goals and Expectations; SIC—Serious Illness Conversation; SICG—Serious Illness Conversation Guide; SICP—Serious Illness Care Program; SQ—Surprise Question.